![](https://webarchive.library.unt.edu/eot2008/20090513065747im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
First-Time Generics -
December 2003
|
Generic Drug Name |
Generic Manufacturer |
Brand Name |
Approval Date |
1 |
FENOLDOPAM MESYLATE INJECTION, USP 10 MG (BASE)/ML PACKAGED IN 10 MG
(BASE)/1 ML AND 20 MG (BASE)/2 ML SINGLE-DOSE AMPULES |
PHARMAFORCE, INC. |
CORLOPAM INJECTION |
12/1/2003 |
2 |
AMIODARONE HYDROCHLORIDE TABLETS 300 MG |
TARO PHARMACEUTICAL INDUSTRIES, LTD. |
AMIODARONE HCL TABLETS |
12/2/2003 |
3 |
AMOXICILLIN TABLETS FOR ORAL SUSPENSION, USP 600 MG |
RANBAXY LABORATORIES LIMITED |
AMOXIL FOR ORAL SUSPENSION |
12/4/2003 |
4 |
BETAMETHASONE DIPROPIONATE CREAM, USP (AUGMENTED) 0.05% (BASE) |
TARO PHARMACEUTICALS USA, INC. |
DIPROLENE AF CREAM (AUGMENTED) |
12/9/2003 |
5 |
BETAMETHASONE DIPROPIONATE CREAM, USP (AUGMENTED) 0.05% (BASE) |
CLAY-PARK LABS, INC. |
DIPROLENE AF CREAM (AUGMENTED) |
12/9/2003 |
6 |
BETAMETHASONE DIPROPIONATE CREAM, USP (AUGMENTED) 0.05% (BASE) |
ALTANA, INC. |
DIPROLENE AF CREAM (AUGMENTED) |
12/9/2003 |
7 |
MIRTAZAPINE ORALLY DISINTEGRATING TABLETS 15 MG AND 30 MG |
BARR LABORATORIES, INC. |
REMERON SOLTAB ORALLY DISINTEGRATING TABLETS |
12/17/2003 |
8 |
METOLAZONE TABLETS, USP 5 MG AND 10 MG |
EON LABS, INC. |
ZAROXOLYN TABLETS |
12/19/2003 |
9 |
METOLAZONE TABLETS, USP 2.5 MG |
EON LABS, INC. |
ZAROXOLYN TABLETS |
12/19/2003 |
10 |
CEFACLOR TABLETS (CHEWABLE) 125 MG, 187 MG, 250 MG, AND 375 MG |
RANBAXY LABORATORIES LIMITED |
CECLOR FOR SUSPENSION |
12/22/2003 |
11 |
BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE TABLETS, USP 50 MG/750 MG/40 MG, RESPECTIVELY |
MIKART, INC. |
ESGIC-PLUS TABLETS |
12/23/2003 |
12 |
NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS 0.180 MG/0.035 MG, 0.215 MG/0.035 MG,
0.250 MG/0.035 MG, PACKAGED AS A TRIPHASIC REGIMEN (28-DAY CYCLE) |
BARR LABORATORIES, INC. |
ORTHO TRI-CYCLIN TABLETS |
|
Back
to Top
Back to Approvals
Date created: 1/5/2004; updated March 16, 2004 |
![](https://webarchive.library.unt.edu/eot2008/20090513065747im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |